No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.

Prescribing medical cannabis to patients with chronic health conditions may improve health-related quality of life (HRQL).

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

There are disparities in overdose mortality, with a pronounced and increasing burden of mortality for Black men and Black women.

HealthDay News — The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women, according to a study published online April 1 in Nature Communications.

Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.

Long-term treatment with mepolizumab, an interleukin-5 inhibitor, demonstrates a favorable safety profile and sustained corticosteroid-sparing benefits among patients with eosinophilic granulomatosis ...

The US Preventive Services Task Force (USPSTF) recommends primary care behavioral counseling interventions to support breastfeeding.

There are substantial rural-urban disparities in cardiometabolic risk factors and cardiovascular diseases among US adults.

Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online.

The FDA has approved Uplizna (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease in adult patients.